CANCER BUZZ cover art

All Episodes

CANCER BUZZ — 304 episodes

#
Title
1

Designing Care That Creates Value for Patients and the Health System

2

A Collaborative Approach to Health Policy Changes

3

Closing the Gap Between Innovation and Implementation: Strategic Partnerships in Oncology

4

Becoming a Smart Consumer of AI as an Oncology Leader

5

BsAbs: Moving from Curiosity to Confidence

6

Innovation in Action: Breaking Down the 2025 ACCC Impact Report

7

Transforming Palliative Care in Oncology

8

Streamlining Access to TIL Cell Therapy for Melanoma

9

Policy in Practice: Change Hits the Clinic

10

Addressing Psychosocial Distress With Psychedelic-Inspired Therapies

11

Set Goals in Today's Health Care Reality

12

Plans for 2026: A Dialogue With ACCC's Executive Director

13

APPs Paving the Way in Leadership

14

Training the Next Generation of Oncology Leaders

15

Introducing Oncology Unscripted

16

CAR T-Cell Therapy Insights from the Field

17

Claudin 18.2 Reshaping Gastric Cancer Treatment

18

Navigating R/R FL: A Patient Centered Approach

19

1st Guest 6 Years Later

20

Championing Lung Cancer Clinical Trials in the VA

21

Exploring FGFR2b in Gastric and GEJ Cancer

22

Unlocking ESR1 Mutations in Breast Cancer

23

Retired Nurses Supporting the Workforce

24

LIVE from NOC: Women Leaders in Oncology

25

LIVE from NOC: Hot Topics

26

LIVE from NOC:Serving a Growing Patient Population

27

LIVE from NOC: Psychosocial Care, Alcohol, Marijuana and more

28

LIVE from NOC: Exec Dir on Unleashing Innovation

29

2025 Trending Now in Cancer Care: Part 2

30

2025 Trending Now in Cancer Care: Part 1

31

A Patient-Centered Approach to CDK4/6 Inhibitors

32

Bridging the AYA Survivorship Gap

33

Real World Models for APP Onboarding

34

Blood Cancer Awareness Month

35

Workplace Culture

36

A Patient and Her Care Team on Trust + Clinical Trials

37

Bridging the Gap: Enhancing Cancer Care Through Financial Navigation

38

Managing CDK4/6 Inhibitor Toxicities in Breast Cancer

39

Increasing Access and Representation in Clinical Trials

40

Stay Ahead of the Curve on CDK4/6 Inhibitor Toxicities

41

Transforming Cancer Detection and Treatment

42

Adopting Machine Learning-Enabled Decision Support to Improve Oncology End-of-Life Outcomes

43

Ambulatory Care Excellence (ACE): Charting a New Path in Ambulatory Care Model and Coordination

44

Optimizing Germline and Somatic Testing in Prostate Cancer

45

Better Bladder Cancer Care, Closer to Home

46

ASCO E-Poster: Immune-Related Adverse Events

47

Implementing a Structured, Scalable Geriatric Oncology Program

48

Shaw at Home: An Oncology Specific Home and Community-Based Palliative Care Program

49

The Coordinator's Perspective – Driving Research Growth From the Ground Up

50

Improving Care Between Clinic Visits: A Sustainable Model for Remote Patient Monitoring

51

5 Ways to Improve Oncology Clinical Trials

52

Navigating Disparities and Challenges in BTC Care

53

Housing at Risk Program (H@RP)

54

Targeting Progress: Patient Perspective on Antibody-Drug Conjugates in Gynecologic Cancer Care

55

Understanding and Meeting the Unique Needs of Adolescents and Young Adults with Cancer

56

Navigating Disparities and Challenges in HCC Care

57

Bridging the Gap: Women's Health and Cancer Screening in Indigenous Communities

58

Shared Decision-Making in CLL

59

Pipeline Partners

60

Screening for Social Determinants of Health (SDOH)

61

Supporting Skin Health in Patients with Breast Cancer

62

LIVE from AMCCBS: AI in Oncology

63

LIVE from AMCCBS: Topline Takeaways

64

LIVE from AMCCBS: President Una Hopkins

65

LIVE from AMCCBS: Future of care ACCC/ASCO

66

LIVE from AMCCBS: President Nadine J. Barrett

67

LIVE from AMCCBS: Leading Policy Change at the State Level

68

LIVE from AMCCBS: Clinical Research Award Winner

69

Key Takeaways from a National Quality Improvement Initiative to Address Disparities in Bladder Cancer Care

70

ACCC Capitol Hill Day

71

Implementing Bispecific Antibodies: The Blueprint for Community Oncology Excellence

72

Missing Voices: Increasing Black Women's Engagement in Patient Reported Outcomes in Breast Cancer Treatment

73

Consumerism, Cultures of Happiness, and AI in Cancer Care

74

Best of ORM

75

Supportive Oncodermatology: Managing Skin, Hair, and Nail Toxicities in Cancer Care

76

Part 7 of a 7 Part Series: Advocating for Patients in Rural Communities

77

Starting Strong: The Role of Fellows in Medical Advocacy

78

Part 6 of a 7 Part Series: Barriers to Accessing Cancer Care in Nigeria

79

Empowering Community Cancer Providers: Resources for Sarcoma Care

80

Part 5 of a 7 Part Series: Lessons Learned in Sweden in Cancer Prevention and Early Detection

81

Part 4 of a 7 Part Series: Working to Improve Survival Rates and Patient Education in Egypt

82

Exploring Bispecific Antibodies in Community Oncology: Overcoming Challenges and Harnessing Opportunities

83

Part 3 of a 7 Part Series: Examining the Public Health Landscape in Brazil

84

Impact of Medicare Part D Changes on Access to Care for Patients with Cancer

85

Part 2 of a 7 Part Series: Advancing Early Detection, Prevention, and Clinical Trial Diversity in Puerto Rico

86

Part 1 of a 7 Part Series: Challenges Faced by Patients with Cancer Across the Globe

87

Empowering Patients with Cancer to Self-Schedule New Patient Consultations

88

Live from NOC: The Hawaiʻi Cancer Consortium

89

Live from NOC: Navigating Access and Equity

90

Live from the NOC Gala

91

Live from NOC: Enhancing Cancer Research Through Patient Advocacy

92

Live from NOC: Realizing Innovation + What's New in 2024

93

Live from NOC: Come Together: A Global Perspective on Cancer Care Delivery

94

Live from NOC: Culturally Tailored Survivorship Care

95

2024 Trending Now in Cancer Care

96

Establishing Goals of Treatment in Relapsed/Refractory Mantle Cell Lymphoma

97

Developing a Health Equity Playbook

98

Shared Decision Making in Relapsed/Refractory Mantle Cell Lymphoma

99

Psychosocial Support in Head and Neck Cancer Care

100

Addressing Sexual Health in Oncology Patients

101

Care Coordination for Advanced Non-Melanoma Skin Cancers

102

A Practice Within a Practice: Integrating Oncodermatology into Comprehensive Cancer Care

103

Adverse Event Management in Relapsed/Refractory Mantle Cell Lymphoma

104

How Do I Say It? Patient-Provider Communication in Diffuse Large B-Cell Lymphoma Care

105

Addressing Frequency of Care to Improve Quality of Life in Patients with Low-Risk Anemia

106

Creating a Community-Wide Safety Net for Centralized Tracking and Management of Incidental Lung Nodule Findings

107

Empowering Laboratory Professionals to Optimize Biomarker Testing

108

A One-Stop Breast Clinic Improves Time to Diagnosis and Patient Satisfaction

109

Defining and Managing Erythropoietin Stimulating Agents (ESAs) Failure in Patients with Low-Risk MDS

110

A Sustainable Model for Improved Quality for Pancreatic Cyst Surveillance and Early Pancreatic Cancer Detection

111

Smart-Texting High-Risk Patients After Chemotherapy Reduces ED Visits

112

Promoting Equitable Care through the 4R Oncology® Model

113

Implementation of a Bispecific T-Cell Engager Therapy Program at a Community Cancer Center

114

Leveraging the EHR to Automate Biosimilar Selection and Streamline the Prior Authorization Process

115

Community CAR T-Cell Patient Identification Framework

116

Social Determinants of Health in Metastatic Breast Cancer

117

Overcoming Barriers to Holistic Survivorship Care for Immunotherapy Patients

118

Integrating Genetic Counselors in Routine Genitourinary Care

119

A Multidisciplinary Approach to Anemia Management in High-Risk MDS and AML

120

Improving Care Delivery to Patients Newly Diagnosed with Breast Cancer

121

Highlights from the ACCC Working Summit: Advancing CAR T-Cell Therapy Care Continuity and Collaborative Patient Education

122

Care Action Plans for People with Cancer

123

Beyond the Brush: Navigating Dental Care in Head & Neck Cancer

124

Navigating the Operational Challenges of Treatment with Bispecific Antibodies

125

Policy Perspectives on Biomarker Testing Coverage for 2024

126

Open Enrollment: Best Practices for End-of-Year Prep

127

Disparities in Accessing Care for AML Patients: Challenges and Solutions

128

Clarifying the Role of Maintenance Therapy

129

A Conversation With ACCC's Outgoing and Incoming Presidents at the ACCC 50th Annual Meeting and Cancer Center Business Summit

130

LIVE from AMCCBS: White House Update

131

LIVE from AMCCBS: Capitol Hill Update

132

LIVE from AMCCBS: Institute for Comprehensive Cancer Care Services

133

LIVE from AMCCBS: New Payments for Patient Navigation

134

LIVE from AMCCBS: Financial Advocacy Resources

135

Making the Case for Head & Neck Cancer Patient Care Navigators

136

The Florez Lab: Increasing Retention and Improving Productivity of Under-Represented in Medicine Trainees

137

BRCA Testing Survey Insights: A Multidisciplinary Perspective on Testing and Treatment for Patients with Breast Cancer

138

Championing an Institutional Culture of Well-being in a Post-Pandemic Oncology Workforce

139

Missed Care Conversations for Patients with DLBCL

140

Community CAR T-Cell Patient Identification Framework

141

The Future of the Patient Experience

142

Highlights from the ACCC Working Summit: Biomarker Testing – Solutions for EHR Integration

143

Developing a Disease-Site Specific Oncology Patient Navigation Program

144

Germline and Somatic Testing for Ovarian Cancer

145

AML Care Coordination in the Community Setting

146

Live from NOC: AI in Precision Oncology

147

Live from NOC: Technology Support for Health Care Workforce

148

Live from NOC: ACCC Priorities for the President's Cancer Panel

149

Live from NOC: Recruiting Strategies

150

Live from NOC: Leadership for Challenging Times

151

Live from NOC: Rural Appalachian Lung Screening Initiative

152

NOC Preview: Biomarker Testing for Medicaid Beneficiaries

153

NOC Preview: Financial Advocacy Guidelines to Mitigate Financial Toxicity

154

Examining Shared Decision-Making in Bladder Cancer Care

155

Importance of Clinical Team to Recognize SCLC

156

Leveraging Technology to Develop an Express Symptom Management Program & Prevent Oncology ED Visits

157

Strategies to Address Regional Barriers to Care in CLL

158

Combatting Caregiver Isolation Through Awareness and Education

159

The Role of the Clinical Trials Navigator

160

Collaborative Care: A Model for Embedding Counseling in Oncology and Palliative Care

161

Practical Tips for Providers to Empower Caregivers

162

Standardizing Comprehensive Biomarker Testing in Non-Small Cell Lung Cancer

163

There is No One-Size-Fits-All Care Plan for Caregivers

164

e-Consults for Immune-Related Toxicities Improve Patient Access and Reduce Costs

165

The Role of Nursing in Post-Pandemic Care of SCLC

166

A Model for Demonstrating Sustainable Outreach for Cancer Screening

167

Caregiving: Examining Psychosocial Care for Those Who Experience Distress Due to Their Caregiving Role

168

Developing an Advanced Practice Radiation Therapist Role

169

Leveraging Technology to Streamline Biomarker Testing

170

Building Support for Patients with NTRK Gene Fusion-Positive Cancer

171

Critical Conversation Strategies for Patients with AML

172

Treating Small Cell Lung Cancer Through Multidisciplinary Enhanced Supportive Care

173

Medical Hypnosis: A Complimentary Therapy for Patients in Active Treatment

174

Strategies to Addressing Disparities in Patients with AML

175

A New Registry Study for a Rare Form of Breast Cancer

176

Biomarker Testing for NTRK Gene Fusions

177

Cancer Care Team Mental Health: Normalizing Helpers Seeking Help

178

Key Highlights from an ACCC Survey on Remote Patient Monitoring

179

Alleviating the Psycho-social Burden of MPNs

180

Myelofibrosis: Advances in Treatment and Therapy

181

ACCC's 2023 Advocacy Agenda and Priorities

182

Symptoms Scoring and Risk Stratification for Myelofibrosis

183

Utilizing Subcutaneous and IV Treatment for Improved Outcomes with Multiple Myeloma Patients

184

A Better Patient Experience in the Management of Incidental Lung Nodules

185

In the Know: New Treatment Guidelines for Myeloproliferative Neoplasms

186

Mitigating the Financial Burden of Cancer Diagnostics

187

Getting the Green Light for Precision Medicine Stewards

188

The Impact of Integrated Care on Myeloproliferative Neoplasms (MPNs)

189

Treatment Options for Patients with Multiple Myeloma Who Are Ineligible for Transplant

190

Best Practices in Caring for Patients with CLL in a Post-COVID Era

191

Addressing Regional Challenges to Equitable Care for Patients with CLL

192

Robots, Biologics, and Advocates: Lessons from the Pharmacy

193

Precision Medicine: Stories from the CRISPR Revolution

194

The Urgency of MPN Treatment – Why Timing Matters

195

The Role of Population Health Navigators

196

Prioritizing a Multidisciplinary Team Approach in the Care of Patients with Small Cell Lung Cancer

197

Nurses' Role in Oral Oncolytics for CLL

198

A Conversation with ACCC Board Member Dr. Nadine Barrett

199

Improving Clinical Efficiency: EHR & MPN10 Integration

200

Multi-Cancer Early Detection: Legislative Landscape

201

Optimizing SCLC Patient Outcomes Through Multidisciplinary Care Coordination

202

Advanced Skin Cancer Care for Rural Populations

203

The Importance of Having Difficult Conversations with Patients

204

Engaging Patients with Small Cell Lung Cancer in Clinical Trials

205

Social Media as a Platform to Deliver Patient Education

206

Navigating Cancer Diagnostics – A Closer Look at the Role of the Precision Medicine Steward

207

Technology That is Transforming Cancer Care

208

Is It time to Cancel the Term "A Cure for Cancer"

209

Overcoming Health Disparities through Remote Patient Monitoring

210

Financial Barriers to Oral Cancer Therapies

211

LIVE from NOC: Leveraging Data to Tackle Workforce Shortages

212

LIVE from NOC: Building Sustainable Coalitions in Your Community

213

LIVE from NOC: A Support Program to Improve Staff Well-Being

214

LIVE from NOC: Advocates Weigh-In on Financial Advocacy Guidelines Update

215

LIVE from NOC: Financial Advocacy Guidelines

216

Successful Integration of Oral Oncolytics

217

Patient Adherence to Oral Targeted Therapies

218

CAR T-cell Therapy: Remote Patient Monitoring

219

Addressing Challenges in Managing Patients Receiving Oral Therapies for HR+, HER2- Breast Cancer

220

Interventional Screening Tools for Malnutrition

221

Sexual Health: All of Me

222

Malnutrition: Screen or Assess?

223

Anti-Cancer Therapy Privileging for APPs

224

Expediting Cancer Treatment Through a Rapid Access APP-Led Diagnostic Clinic

225

Deploying Technology Across an Interdisciplinary Team to Improve Oral Oncolytic Compliance

226

Chemotherapy Care Companion: A Remote Patient Monitoring Program

227

Malnutrition in Cancer Care

228

A Model for Embedding Primary Care in Oncology

229

Oral Cancer Therapy: Adverse Events

230

Addressing Social Determinants of Health through a Medical-Legal Partnership

231

Digital Literacy in Older Adults with Cancer

232

Cannabis and Cancer: Developing a Patient Clinic

233

Advocating for Financial Health

234

Pharmacy Benefit Managers: How Advocacy Led to Action

235

Increasing Clinical Trial Access for Blood Cancers

236

Expanding the Role of Advanced Practitioners to Address the Care Gap

237

Liquid Biopsy: Cancer Detection & Future Synergies

238

Two ACCC Presidential Themes Converge at One Annual Meeting

239

The Promise of MRD Testing in Multiple Myeloma & CLL

240

State Advocacy Matters

241

Jack's Caregiver Coalition

242

Virtual Integrative Services

243

AMCCBS LIVE: Precision Medicine Reimbursement

244

AMCCBS LIVE: Care Measurement

245

AMCCBS LIVE: Cancer Moonshot

246

AMCCBS LIVE: Industry Reconfiguration Trends

247

Digital Patient Assistance Guide

248

Improving Pathology Reports

249

Developments in TIL Cell Therapy

250

The Business Case for Hiring Oncology Social Workers

251

Biomarker Testing Advocacy

252

Genetic Counseling Advocacy

253

Leading with Gratitude

254

QI in Advanced NSCLC

255

A New Deal for Cancer

256

Precision Medicine Disparities

257

Shared Decision-Making in Acute Myeloid Leukemia

258

Genetic Testing & Telehealth

259

Cancer Care's Road to Recovery from the Global Pandemic

260

Supportive Care in Radiation Oncology

261

Financial Advocacy Playbook

262

Coping with Pandemic Grief

263

CLL, COVID-19, & Why Patient Registries Matter

264

Integrating Advanced Practitioners into Research

265

Implementing a Transportation Hub

266

Chronic Lymphocytic Leukemia: Navigating Uncertainty

267

A Summer of Disconnect for Cancer Professionals

268

Advanced Practitioners' Role in Research

269

Oncology Billing & Coding Fundamentals

270

CLL Patient Education in Transitional Times

271

The IT Professional as a Multidisciplinary Team Member

272

Advancing Clinical Trial Equity

273

Myeloma Care Strategies & COVID-19

274

Real-World Lessons from COVID-19

275

Collaboration and Innovation in the Time of COVID-19

276

Impact of COVID-19 on Revenue Optimization

277

COVID-19 Challenges: Managing Patients with CLL

278

What Comes Next for Telehealth?

279

What You Need to Know about Liquid Biopsy

280

The Spiritual Side of Cancer Care

281

Telehealth & Genetics During COVID-19

282

End-of-Life Health Disparities

283

Cultural Humility & Sensitivity

284

Tracking Patient Adherence to Oral Anti-Cancer Medications

285

Building Trust with Marginalized Groups

286

LGBTQ+ Patients with Cancer

287

Telehealth After COVID-19

288

Supporting Caregivers During COVID-19

289

Psychosocial Oncology Services During COVID-19

290

The Promise of Bispecific Antibodies

291

Lung Cancer Screening During COVID-19

292

Managing Oral Anti-Cancer Medications

293

Lung Cancer Awareness Month

294

Shared Decision-Making

295

Biosimilars: What Patients Need to Know

296

Improving Community Clinical Trial Participation

297

Financial Barriers to Biomarker Testing

298

Closing the Gender Gap in Oncology

299

Immunotherapy & Dermatology

300

Lessons Learned from COVID-19

301

Understanding COVID-19 Data

302

Surgical Oncology During COVID-19

303

Reducing Cancer Drug Waste

304

Cancer Screening During COVID-19